IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q3 2018 Holdings

Filed 2018-11-05 | 9 holdings | $22.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$22.4M3,608,17198.1%
Loxo Oncology IncCOM548862101$348.3K2,038,9201.5%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$54.3K1,990,0000.2%
Viewray Inc.(VRAYQ)COM92672L107$16.2K1,735,9880.1%
Transenterix Inc.COM NEW89366M201$13.9K2,389,3520.1%
Cidara Therapeutics Inc.COM171757107$4.5K1,021,1480.0%
Chimerix Inc.(CMRXEUR)COM16934W106$1.8K472,9430.0%
Pernix Therapeutics Hldgs IncDEBT 4.250% 4/071426VAK4$1.1K$2,500,0000.0%
Pernix Therapeutics Hldgs IncCOM NEW71426V306$202210,0000.0%